U.S. market Closed. Opens in 11 hours 18 minutes

ACRS | Aclaris Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue31.25M29.75M6.76M6.48M4.23M10.09M1.68MN/AN/AN/AN/A
Cost of Revenue18.08M11.96M4.71M5.13M4.05M6.85M1.21MN/AN/AN/AN/A
Gross Profit13.17M17.79M2.05M1.35M172.00K3.24M476.00KN/AN/AN/AN/A
Operating Expenses129.48M102.95M67.43M52.26M92.73M138.66M72.90M48.57M20.67MN/AN/A
Selling, General & Admin31.10M25.13M23.62M20.53M27.83M75.65M33.11M15.09M5.33M2.03M1.77M
Research & Development98.38M77.81M43.81M31.73M64.90M63.01M39.79M33.48M15.34M6.51M3.49M
Other Operating Expenses8.51M2.95M-1.14M-424.00K-2.48M2.68MN/AN/AN/A-8.53M-5.26M
Operating Income-97.36M-85.15M-65.38M-50.91M-111.06M-135.41M-72.42M-48.57M-20.67M-8.53M-5.26M
Other Expenses / Income27.47M-1.75M-25.48M-424.00K-2.48M2.68M2.07M488.00K104.00K16.00K21.00K
Before Tax Income-88.85M-86.91M-90.86M-51.34M-113.54M-132.74M-70.35M-48.08M-20.56M-8.52M-5.24M
Income Tax Expenses-367.00K1.75M23.42M-182.00K29.31M2.68M-1.83MN/AN/AN/AN/A
Net Income-88.48M-88.66M-114.28M-51.15M-142.85M-132.74M-68.52M-48.08M-20.56M-8.52M-5.24M
Interest ExpensesN/A4.70MN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding69.81M65.21M56.73M42.54M41.32M32.91M28.10M21.42M6.11M9.26M10.66M
Diluted Shares Outstanding69.81M65.21M56.73M42.54M41.32M32.91M28.10M21.42M6.11M9.26M10.66M
EBITDA-134.41M-79.66M-41.05M-50.91M-74.05M-135.41M-69.95M-48.45M-20.58M-8.52M-5.25M
EBITDA Margin-430.12%-267.74%-607.08%-785.44%-1,751.83%-1,341.93%-4,156.33%0.00%0.00%0.00%0.00%
EBIT-88.85M-82.21M-90.86M-51.34M-113.54M-130.06M-70.35M-48.08M-20.56M-8.52M-5.24M
EBIT Margin-284.32%-276.31%-1,343.96%-791.98%-2,686.11%-1,288.89%-4,180.21%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙